DOYLE WILLIAM F
Insider CIK 1194459 · OPTN Director, 10% owner · ZTS · NERV Director · NVCR Executive Chairman, Director, 10% owner · ELAN Director · PROK Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PROK PROKIDNEY CORP. | A Award deriv | 2026-05-28 | 2026-05-29 | 135,000 | — | $0 | 135,000 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2026-03-03 | 2026-03-05 | 258,445 | — | $0 | 258,445 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2026-03-03 | 2026-03-05 | 30,072 | — | $0 | 288,517 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2026-03-03 | 2026-03-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2026-03-03 | 2026-03-05 | 50,557 | $12.79 | $646.6K | 349,727 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2026-03-03 | 2026-03-05 | 21,330 | $13.43 | $286.5K | 328,397 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2026-03-03 | 2026-03-05 | 200,284 | — | $0 | 400,284 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2025-05-29 | 2025-06-02 | 125,862 | — | $0 | 125,862 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2024-11-29 | 2024-12-03 | 18,169 | — | $0 | 94,499 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2024-05-30 | 2024-06-03 | 62,558 | — | $0 | 62,558 | SEC↗ |
| ELAN Elanco Animal Health Inc | P Buy | 2024-05-21 | 2024-05-23 | 15,000 | $16.98 | $254.7K | 76,330 | SEC↗ |
| ELAN Elanco Animal Health Inc | P Buy | 2024-03-08 | 2024-03-12 | 15,000 | $16.30 | $244.5K | 61,330 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2023-11-30 | 2023-12-04 | 20,374 | — | $0 | 46,330 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2023-06-29 | 2023-07-03 | 48,128 | — | $0 | 48,128 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2022-11-30 | 2022-12-02 | 18,649 | — | $0 | 25,956 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-08-02 | 2022-08-03 | 837 | $69.66 | $58.3K | 551,176 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2022-07-11 | 2022-07-13 | 1,514,326 | — | $0 | 1,514,326 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2022-07-11 | 2022-07-13 | 1,514,326 | — | $0 | 1,514,326 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2022-06-10 | 2022-06-28 | 2,500 | — | $0 | 2,500 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2022-03-08 | 2022-03-09 | 2,385 | $70.10 | $167.2K | 552,013 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2022-03-03 | 2022-03-07 | 14,581 | $80.59 | $1.18M | 14,581 | SEC↗ |
| ELAN Elanco Animal Health Inc | A Award | 2021-11-30 | 2021-12-02 | 7,307 | — | $0 | 7,307 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-08-02 | 2021-08-04 | 995 | $149.38 | $148.6K | 554,398 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2021-06-11 | 2021-06-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 24,338 | $197.00 | $4.79M | 610,251 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 8,814 | $196.07 | $1.73M | 634,589 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,600 | $194.94 | $311.9K | 643,403 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 2,090 | $193.57 | $404.6K | 645,003 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,900 | $192.52 | $365.8K | 647,093 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,400 | $191.26 | $267.8K | 648,993 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 600 | $216.69 | $130.0K | 555,393 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 500 | $214.67 | $107.3K | 555,993 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,500 | $213.35 | $320.0K | 556,493 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 600 | $211.28 | $126.8K | 557,993 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 521 | $210.18 | $109.5K | 558,593 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 2,200 | $209.34 | $460.5K | 559,114 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 4,500 | $207.80 | $935.1K | 561,314 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,284 | $206.35 | $265.0K | 565,814 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,600 | $205.43 | $328.7K | 567,098 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 1,972 | $204.28 | $402.8K | 568,698 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 2,555 | $203.25 | $519.3K | 570,670 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 4,388 | $202.16 | $887.1K | 573,225 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 4,125 | $201.55 | $831.4K | 577,613 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 4,338 | $199.71 | $866.3K | 581,738 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 10,563 | $198.98 | $2.10M | 586,076 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-13 | 2021-04-15 | 13,612 | $197.83 | $2.69M | 596,639 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2021-04-01 | 2021-04-02 | 7,928 | $134.12 | $1.06M | 650,393 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2021-03-31 | 2021-04-02 | 9,259 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2021-03-31 | 2021-04-02 | 9,259 | $125.25 | $1.16M | 658,321 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-07-31 | 2020-08-03 | 896 | $76.39 | $68.4K | 649,062 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2020-06-11 | 2020-06-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 14,439 | $5.65 | $81.6K | 14,439 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-05-11 | 2020-05-12 | 31,332 | $63.73 | $2.00M | 649,958 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-05-08 | 2020-05-11 | 58,767 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-05-08 | 2020-05-11 | 58,767 | $63.84 | $3.75M | 713,193 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-05-08 | 2020-05-11 | 31,903 | $63.50 | $2.03M | 681,290 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-05-07 | 2020-05-11 | 58,768 | — | $0 | 58,767 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-05-07 | 2020-05-11 | 58,768 | $64.77 | $3.81M | 685,419 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-05-07 | 2020-05-11 | 30,993 | $64.74 | $2.01M | 654,426 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-05-06 | 2020-05-07 | 58,768 | — | $0 | 117,535 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-05-06 | 2020-05-07 | 29,881 | $64.27 | $1.92M | 567,883 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-05-06 | 2020-05-07 | 58,768 | $64.15 | $3.77M | 626,651 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-05-05 | 2020-05-07 | 58,768 | — | $0 | 176,303 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-05-05 | 2020-05-07 | 30,283 | $62.47 | $1.89M | 597,764 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-05-05 | 2020-05-07 | 58,768 | $61.40 | $3.61M | 628,047 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-05-04 | 2020-05-06 | 58,768 | — | $0 | 235,071 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-05-04 | 2020-05-06 | 58,768 | $60.48 | $3.55M | 569,279 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-03-06 | 2020-03-10 | 4,320 | $69.53 | $300.4K | 510,511 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-02-28 | 2020-03-02 | 3,893 | $72.22 | $281.2K | 514,831 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2020-02-27 | 2020-03-02 | 9,259 | — | $0 | 9,259 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2020-02-27 | 2020-03-02 | 9,259 | $79.45 | $735.6K | 518,724 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2020-01-17 | 2020-01-22 | 133,777 | $95.00 | $12.71M | 509,465 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-25 | 2019-11-26 | 16,223 | $96.04 | $1.56M | 643,242 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-20 | 2019-11-22 | 149,300 | $90.36 | $13.49M | 660,165 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-20 | 2019-11-22 | 700 | $91.01 | $63.7K | 659,465 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-12 | 2019-11-13 | 2,100 | $82.14 | $172.5K | 809,465 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-12 | 2019-11-13 | 11,118 | $81.59 | $907.1K | 811,565 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-11-11 | 2019-11-13 | 29,782 | $80.11 | $2.39M | 822,683 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2019-07-30 | 2019-08-01 | 10,412 | — | $0 | 10,412 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2019-07-30 | 2019-08-01 | 6,002 | — | $0 | 852,465 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2019-06-27 | 2019-07-01 | 3,500 | $5.50 | $19.3K | 26,111 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2019-06-12 | 2019-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 14,439 | $6.60 | $95.3K | 14,439 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2019-05-31 | 2019-05-31 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-30 | 2019-06-03 | 48,100 | $53.07 | $2.55M | 846,463 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-29 | 2019-05-31 | 1,900 | $53.10 | $100.9K | 894,563 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-09 | 2019-05-10 | 31,460 | $47.37 | $1.49M | 896,463 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-05-08 | 2019-05-09 | 58,768 | — | $0 | 293,839 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2019-05-08 | 2019-05-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2019-05-08 | 2019-05-10 | 115,060 | — | $0 | 115,060 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-08 | 2019-05-09 | 32,218 | $47.52 | $1.53M | 869,155 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-05-08 | 2019-05-09 | 58,768 | $47.62 | $2.80M | 927,923 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-05-07 | 2019-05-09 | 58,768 | — | $0 | 352,607 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-07 | 2019-05-09 | 32,098 | $47.67 | $1.53M | 842,605 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-05-07 | 2019-05-09 | 58,768 | $48.92 | $2.87M | 901,373 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-05-06 | 2019-05-07 | 58,768 | — | $0 | 411,375 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-05-06 | 2019-05-07 | 58,768 | $48.89 | $2.87M | 874,703 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-06 | 2019-05-07 | 29,038 | $48.07 | $1.40M | 815,935 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-05-03 | 2019-05-06 | 58,768 | — | $0 | 470,143 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-05-03 | 2019-05-06 | 58,768 | $44.60 | $2.62M | 844,973 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-05-03 | 2019-05-06 | 29,966 | $45.21 | $1.35M | 786,205 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-05-02 | 2019-05-06 | 58,768 | — | $0 | 528,911 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-05-02 | 2019-05-06 | 58,768 | $43.28 | $2.54M | 816,171 | SEC↗ |
| NVCR NovoCure Ltd | A Award deriv | 2019-03-22 | 2019-03-26 | 44,953 | — | $0 | 44,953 | SEC↗ |
| NVCR NovoCure Ltd | A Award | 2019-03-22 | 2019-03-26 | 24,554 | — | $0 | 942,860 | SEC↗ |
| NVCR NovoCure Ltd | S Sale | 2019-02-28 | 2019-03-01 | 3,097 | $53.68 | $166.2K | 918,306 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2019-02-27 | 2019-03-01 | 9,260 | — | $0 | 18,518 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2019-02-27 | 2019-03-01 | 9,260 | $52.90 | $489.9K | 921,403 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-12-20 | 2018-12-26 | 2,000 | $6.50 | $13.0K | 22,611 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-12-11 | 2018-12-12 | 4,000 | $7.95 | $31.8K | 20,611 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-12-10 | 2018-12-12 | 2,000 | $8.00 | $16.0K | 16,611 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-11-20 | 2018-11-21 | 2,000 | $8.20 | $16.4K | 14,611 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-10-11 | 2018-10-15 | 600 | $10.00 | $6.0K | 12,611 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-09-17 | 2018-09-19 | 1,800 | $10.50 | $18.9K | 12,011 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-09-14 | 2018-09-17 | 200 | $10.50 | $2.1K | 10,211 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-09-13 | 2018-09-17 | 2,000 | $10.50 | $21.0K | 10,011 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-09-11 | 2018-09-11 | 4,011 | $9.72 | $39.0K | 8,011 | SEC↗ |
| NERV Minerva Neurosciences, Inc | P Buy | 2018-09-10 | 2018-09-11 | 4,000 | $9.88 | $39.5K | 4,000 | SEC↗ |
| NVCR NovoCure Ltd | J Other | 2018-08-02 | 2018-08-20 | 187,787 | — | $0 | 438,167 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2018-08-01 | 2018-08-02 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise deriv | 2018-07-16 | 2018-07-18 | 2,330 | — | $0 | 0 | SEC↗ |
| NVCR NovoCure Ltd | M Exercise | 2018-07-16 | 2018-07-18 | 2,330 | $3.59 | $8.4K | 914,473 | SEC↗ |
| OPTN OptiNose, Inc. | J Other deriv | 2018-06-28 | 2018-07-02 | 1,488,366 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | J Other | 2018-06-28 | 2018-07-02 | 2,195,914 | — | $0 | 817,225 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2018-06-07 | 2018-06-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| OPTN OptiNose, Inc. | A Award deriv | 2018-06-07 | 2018-06-11 | 14,439 | $22.50 | $324.9K | 14,439 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2018-05-09 | 2018-05-10 | 28,652 | $28.26 | $809.7K | 912,143 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2018-05-08 | 2018-05-10 | 28,756 | $28.06 | $806.9K | 940,795 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2018-05-07 | 2018-05-08 | 28,804 | $28.01 | $806.8K | 969,551 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2018-05-04 | 2018-05-08 | 28,666 | $27.89 | $799.5K | 998,355 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2018-05-03 | 2018-05-04 | 28,519 | $27.89 | $795.4K | 1,027,021 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2018-05-02 | 2018-05-04 | 293,840 | — | $0 | 587,679 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2018-05-02 | 2018-05-04 | 293,840 | — | $0 | 1,055,540 | SEC↗ |
| NVCR Novocure Ltd | A Award deriv | 2018-02-27 | 2018-03-01 | 27,778 | — | $0 | 27,778 | SEC↗ |
| NVCR Novocure Ltd | A Award deriv | 2018-02-27 | 2018-03-01 | 202,758 | — | $0 | 202,758 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2018-01-22 | 2018-01-24 | 1,549 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2018-01-22 | 2018-01-24 | 1,549 | $3.59 | $5.6K | 92,746 | SEC↗ |
| NERV Minerva Neurosciences, Inc | A Award deriv | 2017-12-10 | 2017-12-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 190,440 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 473 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 334 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 1,142 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 92,543 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 41,160 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 719,225 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion deriv | 2017-10-17 | 2017-10-19 | 4,563 | — | $0 | 0 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion | 2017-10-17 | 2017-10-19 | 3,013,139 | — | $0 | 3,013,139 | SEC↗ |
| OPTN OptiNose, Inc. | C Conversion | 2017-10-17 | 2017-10-19 | 18,803 | — | $0 | 18,803 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2017-06-14 | 2017-06-15 | 6,498 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2017-06-14 | 2017-06-15 | 6,498 | $3.59 | $23.3K | 91,197 | SEC↗ |
| NVCR Novocure Ltd | A Award deriv | 2017-05-02 | 2017-05-04 | 881,519 | — | $0 | 881,519 | SEC↗ |
| NVCR Novocure Ltd | A Award deriv | 2017-05-02 | 2017-05-04 | 881,519 | — | $0 | 881,519 | SEC↗ |
| NVCR Novocure Ltd | A Award deriv | 2017-05-02 | 2017-05-04 | 881,519 | — | $0 | 881,519 | SEC↗ |
| NVCR Novocure Ltd | J Other | 2017-03-08 | 2017-03-09 | 19,732,767 | — | $0 | 43,000 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2017-02-28 | 2017-03-02 | 525,618 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2017-02-28 | 2017-03-02 | 686,836 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2017-02-28 | 2017-03-02 | 324,440 | $7.60 | $2.47M | 19,498,434 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2017-02-28 | 2017-03-02 | 248,285 | $7.60 | $1.89M | 19,775,767 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2017-02-28 | 2017-03-02 | 525,618 | $3.59 | $1.89M | 20,024,052 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2017-02-28 | 2017-03-02 | 686,836 | $3.59 | $2.47M | 19,822,874 | SEC↗ |
| NVCR Novocure Ltd | J Other | 2017-01-03 | 2017-01-04 | 2,242,664 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2016-05-06 | 2016-05-10 | 845,091 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | M Exercise deriv | 2016-05-06 | 2016-05-10 | 8,349 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2016-05-06 | 2016-05-10 | 845,091 | $3.59 | $3.03M | 21,619,678 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2016-05-06 | 2016-05-10 | 2,381 | $12.59 | $30.0K | 84,699 | SEC↗ |
| NVCR Novocure Ltd | M Exercise | 2016-05-06 | 2016-05-10 | 8,349 | $3.59 | $30.0K | 87,080 | SEC↗ |
| NVCR Novocure Ltd | F Tax w/h | 2016-05-06 | 2016-05-10 | 240,976 | $12.59 | $3.03M | 21,378,702 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 3,380,361 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 1,598,626 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 4,590,439 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 453,621 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 2,242,664 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 1,156,837 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 1,121,329 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion deriv | 2015-10-07 | 2015-10-09 | 4,849,836 | — | $0 | 0 | SEC↗ |
| NVCR Novocure Ltd | C Conversion | 2015-10-07 | 2015-10-09 | 2,242,664 | — | $0 | 3,623,538 | SEC↗ |
| NVCR Novocure Ltd | C Conversion | 2015-10-07 | 2015-10-09 | 17,151,049 | — | $0 | 20,774,587 | SEC↗ |
| NVCR Novocure Ltd | X Exercise deriv | 2015-10-05 | 2015-10-06 | 399,659 | $3.54 | $1.41M | 0 | SEC↗ |
| NVCR Novocure Ltd | X Exercise | 2015-10-05 | 2015-10-06 | 399,659 | $3.54 | $1.41M | 1,380,874 | SEC↗ |